Johnson & Johnson MedTech Executive and Leadership Team

Tino Schweighoefer, the Chief Financial Officer, Monarch Platform at Johnson & Johnson MedTech, oversees the financial strategy and operations specifically for the Monarch Platform. Schweighoefer directs financial planning, analysis, and reporting, ensuring fiscal health and driving profitable growth for this critical business segment. This leadership position involves managing budgets, forecasting financial performance, and identifying investment opportunities to advance the platform's technological capabilities. Schweighoefer collaborates with product development and commercial teams to align financial resources with strategic goals, supporting the creation of advanced healthcare solutions. The financial oversight extends to optimizing resource allocation and ensuring compliance with financial regulations across global operations. Schweighoefer's expertise is vital in guiding the financial trajectory of the Monarch Platform, a key component of Johnson & Johnson MedTech's innovative engineering efforts. The objective is to maximize financial returns while supporting the platform's role in transforming medical intervention capabilities.

Gigi Chang, the Chief Financial Officer, Medtech (Canada) at Johnson & Johnson MedTech, directs the financial operations and strategic planning for the Canadian MedTech division. Chang manages financial reporting, budgeting, and forecasting, ensuring the fiscal integrity and profitability of the Canadian market operations. This role involves close collaboration with regional leadership to drive financial performance and support business growth initiatives within Canada. Chang oversees financial controls and compliance, adhering to both local regulations and global corporate standards. The financial leadership provided by Chang is crucial for optimizing resource allocation and identifying key investment areas that align with the company's broader objectives of developing advanced healthcare solutions. Chang's strategic financial guidance supports the expansion of purposeful technology and innovative engineering within the Canadian healthcare landscape. The focus is on achieving sustainable financial success and contributing to the overall mission of transforming medical intervention capabilities.

Oray Boston, the President, Worldwide of Trauma, Extremities, Craniomaxillofacial, Animal Health & Sports Medicine at Johnson & Johnson MedTech, directs global strategy and operations for a diverse portfolio of specialized medical device segments. Boston drives market expansion and product innovation across trauma, reconstructive surgery, and veterinary care, ensuring these areas contribute significantly to the company's overall mission. This leadership position involves overseeing commercial teams, product development pipelines, and strategic partnerships to enhance market penetration and revenue growth. Boston's focus is on leveraging advanced healthcare solutions and purposeful technology to meet the unique needs of patients and clinicians in these critical fields. The global scope of this role requires extensive coordination across North America, Europe, Asia, and other key regions. Boston's leadership ensures that Johnson & Johnson MedTech remains at the forefront of developing innovative engineering for specialized medical interventions. The objective is to solidify market leadership and drive advancements in patient outcomes worldwide.

Ryan Benishake, the Co-Distributor Principal and President of One Medtech East, Inc. at Johnson & Johnson MedTech, leads distribution and sales initiatives for a significant regional market. Benishake drives the commercial strategy for medical devices and healthcare solutions within the East region, ensuring effective market access and customer engagement. This role involves managing distributor relationships and optimizing sales channels to support the company's growth objectives. Benishake's leadership focuses on translating the company's commitment to purposeful technology into tangible market success. The operational scope includes ensuring efficient delivery and support for advanced healthcare products, aligning with the company's global mission. Benishake collaborates with internal teams to align distribution strategies with product development and marketing efforts, enhancing the reach of innovative engineering. The objective is to maximize market share and customer satisfaction through superior distribution and sales execution in the designated territories.

Sharrolyn Josse, the Global President Joint Reconstruction- Hips, Knees and Shoulders at Johnson & Johnson MedTech, directs the worldwide strategy and commercial execution for critical orthopedic implant solutions. Josse drives innovation and market leadership in hip, knee, and shoulder reconstruction, ensuring these product lines advance patient care and surgical outcomes. This executive role involves overseeing global product development, sales, and marketing efforts, fostering growth across diverse international markets. Josse's leadership focuses on leveraging advanced healthcare solutions and purposeful technology to address the needs of a growing patient population requiring joint replacement. The strategic vision guides the development of cutting-edge medical devices that enhance mobility and quality of life. Josse collaborates with R&D and clinical teams to ensure product portfolios remain at the forefront of orthopedic innovation. The objective is to expand access to superior joint reconstruction technologies and solidify Johnson & Johnson MedTech's position as a leader in this field.

Nisha Johnson, the Global President J & J MedTech Wound Closure and Healing at Johnson & Johnson MedTech, leads the strategic vision and operational execution for a comprehensive portfolio of wound care solutions. Johnson drives innovation in advanced wound closure and healing technologies, aiming to improve patient recovery and reduce healthcare burdens globally. This executive position oversees product development, commercial strategies, and market expansion initiatives across all regions. Johnson's leadership emphasizes the integration of purposeful technology and innovative engineering to create effective medical devices for wound management. The focus is on addressing unmet clinical needs and enhancing the standard of care in wound healing. Johnson collaborates with cross-functional teams to ensure product quality, efficacy, and market accessibility. The objective is to maintain Johnson & Johnson MedTech's leadership in wound closure and healing by delivering transformative solutions that positively impact patient lives worldwide.

Steven Henn, the Global President, Biosurgery at Johnson & Johnson MedTech, directs the global strategy and commercial operations for the biosurgery division, focusing on innovative solutions for surgical procedures. Henn drives the development and market adoption of advanced biosurgical products that enhance surgical precision and patient outcomes. This leadership role involves overseeing product innovation, market access, and strategic partnerships to expand the reach of biosurgery technologies worldwide. Henn's focus is on leveraging purposeful technology and sophisticated engineering to create medical devices that meet critical clinical demands. The scope includes managing a global team dedicated to advancing the field of biosurgery. Henn collaborates with research and development to ensure a robust pipeline of next-generation products. The objective is to solidify Johnson & Johnson MedTech's position as a leader in biosurgery by providing clinicians with state-of-the-art solutions that improve surgical performance and patient recovery.

Yvan Francois, the Chief of Staff To the Executive Vice President and WW Chain JJMedTech at Johnson & Johnson MedTech, directs critical operational support and strategic alignment for executive initiatives. Francois manages key projects and communications, ensuring seamless execution of the Executive Vice President's vision across global MedTech operations. This role involves close collaboration with functional leaders to drive efficiency and strategic progress. Francois supports the development and implementation of key business strategies, acting as a central point for information flow and decision support. The scope of this position encompasses coordinating cross-functional teams to achieve specific business objectives and enhance operational performance. Francois's leadership ensures that strategic priorities are translated into actionable plans, contributing directly to the company's mission of creating purposeful technology for medical interventions. The focus remains on optimizing processes and facilitating effective decision-making within the global MedTech framework.

Sword Zheng, the Chief Human Resources Officer at Johnson & Johnson MedTech, leads the strategic direction for all human capital initiatives across the organization. Zheng cultivates a high-performance culture, driving talent acquisition, development, and retention strategies to support the company's mission of advancing healthcare solutions. This executive role involves shaping organizational design, fostering employee engagement, and ensuring robust HR policies that align with business objectives. Zheng collaborates with leadership teams to build a diverse and skilled workforce capable of innovating and executing complex medical device development. The focus is on creating an environment where employees can thrive and contribute to the company's global impact. Zheng's leadership ensures that human resources functions effectively support the company's commitment to purposeful technology and engineering excellence. Strategic workforce planning and talent management are central to Zheng's responsibilities, underpinning the company's ability to deliver cutting-edge medical devices worldwide.

Randall Jones, the Chief Medical Officer at Johnson & Johnson MedTech, provides critical medical and scientific leadership to guide the development and application of advanced healthcare solutions. Jones ensures that all medical devices and technologies align with the highest standards of patient safety and clinical efficacy, directly supporting the company's mission. This executive role involves overseeing clinical strategy, regulatory affairs, and medical affairs functions, bridging the gap between scientific innovation and practical medical intervention. Jones collaborates with R&D and engineering teams to translate clinical insights into purposeful technology, driving the creation of innovative medical devices. The medical oversight extends to ensuring that products meet the evolving needs of healthcare professionals and patients globally. Jones's expertise is fundamental to maintaining the company's reputation for quality and innovation in medical technology. The focus is on advancing medical intervention capabilities through evidence-based development and rigorous clinical validation.